iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Bought by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC lifted its stake in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) by 1,763.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,596 shares of the company's stock after buying an additional 3,403 shares during the quarter. Tower Research Capital LLC TRC's holdings in iRhythm Technologies were worth $324,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. R Squared Ltd purchased a new stake in shares of iRhythm Technologies during the fourth quarter valued at approximately $45,000. Van ECK Associates Corp lifted its holdings in iRhythm Technologies by 41.3% in the 4th quarter. Van ECK Associates Corp now owns 554 shares of the company's stock worth $50,000 after buying an additional 162 shares in the last quarter. Nisa Investment Advisors LLC boosted its position in iRhythm Technologies by 166.6% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,037 shares of the company's stock valued at $94,000 after buying an additional 648 shares during the last quarter. KBC Group NV grew its stake in shares of iRhythm Technologies by 45.1% during the fourth quarter. KBC Group NV now owns 1,319 shares of the company's stock valued at $119,000 after acquiring an additional 410 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new stake in shares of iRhythm Technologies during the third quarter worth about $119,000.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on IRTC shares. Canaccord Genuity Group reduced their target price on iRhythm Technologies from $152.00 to $139.00 and set a "buy" rating for the company in a research note on Friday. Needham & Company LLC raised their price objective on shares of iRhythm Technologies from $138.00 to $151.00 and gave the stock a "buy" rating in a report on Friday. Truist Financial upped their target price on shares of iRhythm Technologies from $111.00 to $145.00 and gave the company a "buy" rating in a research note on Friday, February 21st. Oppenheimer boosted their price objective on iRhythm Technologies from $105.00 to $120.00 and gave the company an "outperform" rating in a report on Wednesday, January 8th. Finally, StockNews.com upgraded iRhythm Technologies from a "sell" rating to a "hold" rating in a research report on Monday, February 24th. Two equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $128.55.

iRhythm Technologies Stock Performance

IRTC traded up $4.64 during trading on Monday, reaching $135.76. 1,269,219 shares of the company were exchanged, compared to its average volume of 467,000. The company has a current ratio of 6.27, a quick ratio of 6.12 and a debt-to-equity ratio of 9.00. The stock has a market cap of $4.33 billion, a P/E ratio of -37.30 and a beta of 1.34. iRhythm Technologies, Inc. has a 52 week low of $55.92 and a 52 week high of $138.42. The firm has a 50 day moving average of $104.12 and a 200 day moving average of $96.91.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported ($0.95) earnings per share for the quarter, missing analysts' consensus estimates of ($0.89) by ($0.06). The firm had revenue of $158.68 million during the quarter, compared to analyst estimates of $153.39 million. iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.14%. The firm's revenue was up 20.3% on a year-over-year basis. During the same period last year, the business earned ($1.23) EPS. On average, sell-side analysts forecast that iRhythm Technologies, Inc. will post -1.98 EPS for the current fiscal year.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.